TaiGen Announces FDA Approval of IND for Its Flu Antiviral TG-1000

TaiGen Biotechnology Company, Limited (“TaiGen”) (Taiwan: 4157) announced today that U.S. Food and Drug Administration (“FDA”) has approved the Investigation New Drug (IND) application for TG-1000, a …
( read original story …)

---